More on ACRV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.1 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Acrivon Therapeutics (NQ:ACRV)
Delayed: 2.07 -0.02 (0.96%)
Prev. Close $2.09  
Open$2.07 
52 Wk High$ 
52 Wk Low$ 
Day High$2.13 
Day Low$2.03 
P/E N/A  
EPS$ 
Volume356,518 

Friends, Peers and Foes (?): INCY, ACET, ARVN, AZN, BCAB (more...)

Aug 31, 2026 08:32 AM Acrivon Therapeutics names Michaela Levin as chief business officer
Aug 31, 2026 08:30 AM Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
Aug 27, 2026 04:15 PM Form 4 Acrivon Therapeutics, For: Aug 25 Filed by: Blume-Jensen Peter
Aug 25, 2026 08:40 PM Form 144 Acrivon Therapeutics, Filed by: Blume-Jensen Peter
Aug 20, 2026 04:10 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Peterson Katharine
Aug 20, 2026 04:09 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Miller Mary
Aug 20, 2026 04:08 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Gamelin Erick
Aug 20, 2026 04:08 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Devroe Eric
Aug 20, 2026 04:07 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Blume-Jensen Peter
Aug 13, 2026 11:32 AM Form SCHEDULE 13G/A Acrivon Therapeutics, Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
View All Articles

Entities mentioned with ACRV

View All Entities